S
CCEL icon

SignatureFD’s Cryo-Cell International CCEL Stock Holding History

SignatureFD’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$355 Hold
100
– – ﹤0.01% 3344
2025
Q4 		$344 Hold
100
– – ﹤0.01% 3265
2025
Q3 		$464 Hold
100
– – ﹤0.01% 3201
2025
Q2 		$519 Hold
100
– – ﹤0.01% 3101
2025
Q1 		$637 Buy
+100
New +$726 ﹤0.01% 3134

Other funds holding CCEL

SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SignatureFD's CCEL Position: Q1 2026 in Review

SignatureFD held its Cryo-Cell International (CCEL) position steady in Q1 2026 at 100 shares worth $355. The position accounts for ﹤0.01% of the portfolio, ranked #3344.

SignatureFD first reported a position in CCEL in Q1 2025 and has held it in 5 quarters since. The position peaked at $637 in Q1 2025. 11 funds tracked by Wall St. Rank hold CCEL as of Q1 2026.

  • SignatureFD held 100 shares of Cryo-Cell International worth $355 as of Q1 2026.
  • SignatureFD left its Cryo-Cell International share count unchanged in Q1 2026.
  • Cryo-Cell International made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #3344 holding.
  • SignatureFD first reported a position in Cryo-Cell International in Q1 2025 and has held it in 5 quarters since.
  • SignatureFD's Cryo-Cell International position peaked at $637 in Q1 2025.
  • 11 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.